Clinical factors affecting quality of the response to Stelara for psoriasis

Linear Mode

Clinical factors affecting quality of the response to Stelara for psoriasis

mataribot Offline

100 + Member I Just Cant Stop !

Posts: 1,340
Threads: 38
Joined: Jun 2013
Gender: Male
Location: USA
Treatment: >_<

Thu-10-07-2014, 01:04 AM

"The patients, who showed a <74% reduction in the PASI score, were classified as insufficient-responders." That's just an insanely high tolerance. Fred, I bet you would be considered a insufficient responder. Sounds like someone doesn't want to pay for treatment.

Quote

« Next Oldest | Next Newest »

Messages In This Thread

Clinical factors affecting quality of the response to Stelara for psoriasis - by Fred - Wed-09-07-2014, 20:20 PM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by jiml - Wed-09-07-2014, 20:37 PM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by Fred - Wed-09-07-2014, 20:49 PM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by jiml - Wed-09-07-2014, 20:58 PM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by Fred - Wed-09-07-2014, 21:05 PM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by Bill - Thu-10-07-2014, 00:17 AM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by mataribot - Thu-10-07-2014, 01:04 AM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by Caroline - Thu-10-07-2014, 07:17 AM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by mataribot - Thu-10-07-2014, 07:36 AM

RE: Clinical factors affecting quality of the response to Stelara for psoriasis - by Bill - Thu-10-07-2014, 13:31 PM

Possibly Related Threads…
Thread		Author	Replies	Views	Last Post
	Vulval psoriasis and Impact on quality of life	Fred	7	1,389	Fri-02-05-2025, 15:38 PM Last Post: Forest Walker
	Otezla (apremilast) quality of life, efficacy, and safety study	Fred	1	2,587	Tue-01-11-2022, 03:14 AM Last Post: mataribot
	Tremfya super response study	Fred	4	4,259	Thu-04-08-2022, 19:34 PM Last Post: mataribot
	IMG-004 starts phase I clinical trial	Fred	2	2,749	Tue-17-05-2022, 06:48 AM Last Post: Caroline
	Evelo Announces Positive Phase 2 Clinical Data with EDP1815 in Psoriasis	Fred	0	2,021	Tue-28-09-2021, 20:59 PM Last Post: Fred

Users browsing this thread:

Login
Username:
Password:	Lost Password?
	Remember me